Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
2020
515 citations
Journal Article
Field-Weighted Citation Impact:
24.55
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial | Researchclopedia
·
Tel Aviv University
Ravit Geva
·
Tel Aviv University
Mitesh J. Borad
·
Mayo Clinic in Arizona
Katrina S. Pedersen
·
Washington University in St. Louis
Joon Oh Park
·
Samsung Medical Center
Robert A. Ramirez
·
Ochsner Medical Center
David Gutiérrez Abad
·
Hospital Universitario de Fuenlabrada
Jaime Feliú
·
Hospital Universitario La Paz
Andrés Muñoz
·
Hospital General Universitario Gregorio Marañón
Mariano Ponz‐Sarvisé
·
Clinica Universidad de Navarra
Amnon Peled
·
Hebrew University of Jerusalem
Tzipora M Lustig
Osnat Bohana‐Kashtan
Stephen M. Shaw
Ella Sorani
Marya Chaney
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Shaul Kadosh
Abi Vainstein Haras
Daniel D. Von Hoff
·
Translational Genomics Research Institute
Manuel Hidalgo
·
NewYork–Presbyterian Hospital